Product Pathways - Tyrosine Kinase / Adaptors
MATK/CHK (D2I6U) Rabbit mAb #20729
|20729S||100 µl ( 10 western blots )||￥3,250.00||现货查询 购买询价 防伪查询|
|20729||carrier free & custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation,
Specificity / Sensitivity
MATK/CHK (D2I6U) Rabbit mAb recognizes endogenous levels of total MATK/CHK protein.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Glu97 of human MATK/CHK protein.
Western blot analysis of extracts from GDM-1, HL-60 and CMK cell lines using MATK/CHK (D2I6U) Rabbit mAb.
MATK/CHK (CTK, NTK and HYL) is a non-receptor tyrosine kinase structually and functionally homologous to Csk kinase. The kinase was identified through molecular cloning from multiple tissues by different research groups. Like Csk, MATK/CHK has a N-terminal SH3 domain, followed by an SH2 domain and a C-terminal catalytic kinase domain (1-4). MATK/CHK inhibits Src family members in several different ways. First, it directly phosphorylates the inhibitory C-terminal tyrosine of Src (as well as other Src family members). This induces a Src protein conformational change from the active to inactive state (2,4). Second, it binds directly to activated Src and induces a conformational change to the inactive state (5,6). The SH2 domain of MATK/CHK directly interacts with the phosphorylated tyrosine of activated receptor tyrosine kinases, such as ErbB-2 and c-Kit, to inhibit receptor function (7-9). MATK/CHK negatively regulates tumor cell growth, migration and invasion (10-13). Decreased expression of the protein has been correlated with brain tumors as well as colon cancers in research studies (14-15).
- Sakano, S. et al. (1994) Oncogene 9, 1155-61.
- Chow, L.M. et al. (1994) Proc Natl Acad Sci U S A 91, 4975-9.
- Bennett, B.D. et al. (1994) J Biol Chem 269, 1068-74.
- Klages, S. et al. (1994) Proc Natl Acad Sci U S A 91, 2597-601.
- Chong, Y.P. et al. (2004) J Biol Chem 279, 20752-66.
- Chong, Y.P. et al. (2006) J Biol Chem 281, 32988-99.
- Zrihan-Licht, S. et al. (1998) J Biol Chem 273, 4065-72.
- Kim, S. et al. (2002) J Biol Chem 277, 36465-70.
- Price, D.J. et al. (1997) J Biol Chem 272, 5915-20.
- Lee, B.C. et al. (2005) Cancer Res 65, 2840-5.
- McShan, G.D. et al. (2002) Int J Oncol 21, 197-205.
- Fu, Y. et al. (2006) Int J Oncol 29, 1453-8.
- Dokmanovic, M. et al. (2014) Cancer Biol Ther 15, 1029-41.
- Zhu, S. et al. (2008) Oncogene 27, 2027-34.
- Kim, S.O. et al. (2004) Cancer 101, 1018-27.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 7003 20X LumiGLO® Reagent and 20X Peroxide
- 7071 Phototope-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
Tween is a registered trademark of ICI Americas, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
用户评论 --- 共 0 条